NCT03435042 A Hypnosis-based Group Intervention to Improve Quality of Life in Children With Cancer and Their Parents.
| NCT ID | NCT03435042 |
| Status | Recruiting |
| Phase | — |
| Sponsor | University of Liege |
| Condition | Pediatric Cancer |
| Study Type | INTERVENTIONAL |
| Enrollment | 30 participants |
| Start Date | 2018-01-25 |
| Primary Completion | 2028-12-31 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.
This trial targets 30 participants in total. It began in 2018-01-25 with a primary completion date of 2028-12-31.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
Background: A lot of children with cancer suffer from emotional distress, fatigue and relational difficulties. Their parents are also impacted by the disease: their responsibilities increase and they can feel more distressed and tired. Different psychological interventions designed for ill children and their parents seem to be efficient to improve their social functioning, coping strategies and well-being. However, more research is needed in this field. Hypnosis is often used in paediatric oncology, mostly to decrease procedure-related pain and distress. It has been used efficiently to improve the well-being of adults with cancer. This paper describes a pilot study designed to assess the feasibility and interest of a group intervention combining self-care and hypnosis for children with cancer and their parents, and a quasi-experimental protocol aimed at assessing the efficacy of this group intervention to improve the quality of life of children and their parents. Methods: Our pilot study showed that our intervention was feasible and positive for the participants. To test the efficacy of the intervention, two groups will be set up: one with children with cancer and their interested siblings, and one with their parents. Data will be collected for each group before and after the intervention by questionnaires and a semi-structured interview. Discussion: There is a growing interest in hypnosis in oncology settings. The results of this study should improve knowledge about the efficacy of a group intervention combining self-care and hypnosis to improve quality of life of children with cancer and their family.
Eligibility Criteria
Inclusion Criteria: * Children and their siblings: * To be 8 to 18 year-old * To suffer from cancer (all localisations, stage and treatments accepted) or to have a sibling who suffer from cancer * To speak french * Parents: * To have a child who suffer from cancer * To speak french Exclusion Criteria: * /
Contact & Investigator
Marie-Elisabeth Faymonville
STUDY DIRECTOR
Centre Hospitalier Universitaire de Liege
Frequently Asked Questions
Who can join the NCT03435042 clinical trial?
This trial is open to participants of all sexes, aged 8 Years or older, studying Pediatric Cancer. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT03435042 currently recruiting?
Yes, NCT03435042 is actively recruiting participants. Contact the research team at ch.gregoire@uliege.be for enrollment information.
Where is the NCT03435042 trial being conducted?
This trial is being conducted at Liège, Belgium.
Who is sponsoring the NCT03435042 clinical trial?
NCT03435042 is sponsored by University of Liege. The principal investigator is Marie-Elisabeth Faymonville at Centre Hospitalier Universitaire de Liege. The trial plans to enroll 30 participants.
Related Trials
Related Intelligence Guides
In-depth guides covering this condition's trials, eligibility, and what to expect.